Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sgt-001 (1 trial)
sgt-003 (1 trial)
Muscular Dystrophies (Phase 2)
Muscular Dystrophy, Duchenne (Phase 2)
Trials (2 total)
Trial APIs (2 total)